The DOI matches its Crossref record.
New cancer treatment strategy using combination of green tea catechins and anticancer drugs
Open accessAbstract
Green tea is now recognized as the most effective cancer preventive beverage. In one study, 10 Japanese‐size cups of green tea daily supplemented with tablets of green tea extract limited the recurrence of colorectal polyps in humans to 50%. Thus, cancer patients who consume green tea and take anticancer drugs will have double prevention. We studied the effects of combining (−)‐epigallocatechin gallate (EGCG) and anticancer drugs, focusing on inhibition of cell growth and induction of apoptosis. Numerous anticancer drugs, such as tamoxifen, COX‐2 inhibitors, and retinoids were used for the experiments, and the combination of EGCG and COX‐2 inhibitors consistently induced the enhancement of apoptosis. To study the mechanism of the enhancement, we paid special attention to the enhanced expressions of DDIT3 (growth arrest and DNA damage‐inducible 153, GADD153), GADD45A, and CDKN1A (p21/WAF1/CIP1) genes, based on our previous evidence that a combination of EGCG and sulindac specifically induced upregulated expression of GADD153 and p21 genes in PC‐9 lung cancer cells. The synergistic enhancements of apoptosis and GADD153 gene expression in human non‐small cell lung cancer cells by the combination of EGCG and celecoxib were mediated through the activation of the MAPK signaling pathway. This article reviews the synergistic enhancement of apoptosis, gene expression, and anticancer effects using various combinations of EGCG and anticancer drugs, including the combination of (−)‐epicatechin (EC) and curcumin. Based on the evidence, we present a new concept: green tea catechins as synergists with anticancer drugs. (Cancer Sci 2011; 102: 317–323)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Chronic Inflammation in Cancer Development
Multhoff, G., Molls, M., & Radons, J. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00098 · Cited by 576
The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry
Ciesek, S., von Hahn, T., Colpitts, C. C., Schang, L. M., Friesland, M., Steinmann, J., Manns, M. P., Ott, M., Wedemeyer, H., Meuleman, P., et al. (2010) · Hepatology · doi:10.1002/hep.24610 · Cited by 303
Malongane, F., McGaw, L. J., & Mudau, F. N. (2017) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.8472 · Cited by 161
Human cancer stem cells are a target for cancer prevention using (−)-epigallocatechin gallate
Fujiki, H., Sueoka, E., Rawangkan, A., & Suganuma, M. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2515-2 · Cited by 64
Self-citation
Metadata
- Authors
- Suganuma, M., Saha, A., & Fujiki, H.
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2010-12-30
- Volume
- 102
- Issue
- 2
- Pages
- 317-323
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- OpenAlex
- W2150252158
- Cited by
- 185
- References
- 0
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New cancer treatment strategy using combination of green tea catechins and anticancer drugs. https://app.cochat.ai/papers/10.1111/j.1349-7006.2010.01805.x
- The paper
- Suganuma, M., Saha, A., & Fujiki, H. (2011). New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Science. https://doi.org/10.1111/j.1349-7006.2010.01805.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.